HAUSMAN DIANA 4
4 · Zentalis Pharmaceuticals, Inc. · Filed May 9, 2024
Insider Transaction Report
Form 4
HAUSMAN DIANA
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1]2024-05-09$12.62/sh−3,356$42,353→ 373,876 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
Signature
/s/ Andrea Paul, attorney-in-fact for Diana Hausman|2024-05-09